With respect to T2DM, the severity of GDM—often categorized by the type of treatment required, whether managed through diet, oral hypoglycemic agents, or insulin—[26] and the degree of insulin resistance, βcell-dysfunction and the presence of obesity are all independent factors that could influence the risk of developing T2DM later in life [9]. Here, INS is linked to Insulin resistance.